InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,667.20
(
0.64%
)
US TECH 100
19,853.60
(
0.00%
)
Dow Jones
40,954.48
(
1.85%
)
Brent Oil
83.38
(
0.07%
)
Bitcoin
65,340.39
(
0.38%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bellweather1

Send PM Follow Ignore
Followers 11
Posts 2370
Boards Moderated 0
Alias Born 06/08/2010

bellweather1

Re: None

Friday, 09/16/2011 11:10:29 AM

Friday, September 16, 2011 11:10:29 AM

Post# of 80490
Goldman upgrades "biotech" to neutral-

>>>Thanks!

referring to defensive biotechs with dependable revenue streams-

suggested these can negotiate the macro vol better than many sectors.

Though Ariad doesn't yet technically qualify, big reason I've characterized it (and bet on it)as relatively recession proof, is because of the imminent revenue stream in areas of indisputable need.

Glad to see the all knowing "Goldman" has come around to appreciating the value of the sector for this(they like GILD), if not yet Ariad.

Like Jeffries, they too will eventually come around.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up